Search

ISSN: 1735-403X eISSN: 2383-2886

October 2024, Vol 30, No. 4

Pharmaceutical Sciences is a peer-reviewed, and quarterly journal providing a forum for basic to clinical issues related to all areas of pharmaceutical sciences. It is the official journal of Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.
- Platinum Open Access (no processing or publication fees)
- Indexed in Web of Science Core Collection (Impact Factor 2023= 1.4) and Scopus (CiteScore 2023= 2.6)
- Average time to first decision in 2023 (all decisions): 17 days
- Time to first post-review decision in 2023: 2-8 weeks
- Acceptance rate in 2023: 10%
- Publications from 18 countries (5 continents) in 2023

Original Research

1. Pharmacokinetics and Bioequivalence Study of Amlodipine and Atorvastatin in Healthy Male Volunteers by LC-MS

Hossein Danafar*, Mehrdad Hamidi

Pharm Sci. 2015;21(Special Issue in Honor of Professor Barzegar-Jalal): 167-174. doi: 10.15171/PS.2015.32

Scopus ID: 84948761065

Article

PDF

XML

Cited By:

25

16

Research Article

2. Application of Multivariate Calibration Methods, in Dissolution Testing and Simultaneous Determination of Atorvastatin and Ezetimibe in Their Combined Solid Dosage Form

Azin Jahangiri, Khosro Adibkia, Karim Asadpour-Zeynali, Yousef Javadzadeh, Hamed Hamishehkar, Mohammad Barzegar-Jalali*

Pharm Sci. 2016;22(2): 105-111. doi: 10.15171/PS.2016.17

Scopus ID: 84977106655

Article

PDF

XML

Cited By:

7

4

Research Article

3. Response Surface Methodology for Optimization of Process Variables of Atorvastatin Suspension Preparation by Microprecipitation Method Using Desirability Function

Maryam Maghsoodi , Seyed hassan Montazam, Hossein Rezvantalab, Mitra Jelvehgari*

Pharm Sci. 2020;26(1): 61-74. doi: 10.34172/PS.2019.52

Scopus ID: 85084567978

Article

PDF

XML

Cited By:

2

1

Research Article

4. A Comparison on Effects of High Dose Rosuvastatin versus High Dose Atorvastatin on Lipid Profile and CRP Level in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Study

Mahboubeh Darban , Elham Yusefabadi, Majid Mirmohammad Khani, Bahram Sohrabi, Bahador Bagheri*

Pharm Sci. 2021;27(4): 568-574. doi: 10.34172/PS.2021.5

Scopus ID: 85127106747

Article

PDF

XML

Cited By:

0

0

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE

Powered by: